Addressing HEK293 cell lineage and AAV diversity with media panel
Cell & Gene Therapy Insights 2021; 7(9), 933
Watch the video or read the poster to learn:
- Understanding diversity in HEK cell lineages
- Significance of media screening in AAV process development
- Factors driving performance beyond titer
- Importance of adaptation strategy in media screening
We hope you enjoyed this FastFacts video. You can also view the summary PDF here.
Authorship & Conflict of Interest
Contributions: All named authors take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.Acknowledgements: None
Disclosure and potential conflicts of interest: The author is an employee of Thermo Fisher Scientific. The author has no other conflicts of interest to disclose.
Funding declaration: The authors received no financial support for the research, authorship and/or publication of this article.
Article & copyright information
Copyright: Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.
Attribution: Copyright © 2021 Thermo Fisher Scientific. Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0.
Article source: From a Fast Facts video recorded on: Aug 11 2021; Publication date: Sep 29 2021.